Effect of L-carnitine in treatment of non-alcoholic fatty liver

investigation the effectiveness of simultaneous administration of L-carnitine and aerobic exercise compared to placebo and aerobic exercise on changes in the ultrasound grade of fatty liver and liver enzyme levels in patients with non-alcoholic fatty liver

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240828062893N1

Enrollment

120

Registered

2024-12-28

Start date

2025-01-20

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-alcoholic fatty liver. Fatty (change of) liver, not elsewhere classified

Interventions

Intervention 1: Intervention group: Patients receiving L-Carnitine 1000 tablets (the tablets are not chewable and should be taken with water, and the timing of the medication is half an hour before ae

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: age over 18 years diagnosis of non alcoholic fatty liver disease (NAFLD)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Measurement of Disease Stage. Timepoint: Before and 3 months after treatment. Method of measurement: By means of liver ultrasound.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Hasanzarrini

Hamedan University of Medical Sciences

m.hasanzarrini@umsha.ac.ir+98 81 3828 0078

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026